| Dr Ren Masami Kinoshita, DO | |
|
1301 Punchbowl St, Queen's Medical Center, Honolulu, HI 96813-2402 | |
| (808) 779-0780 | |
| Not Available |
| Full Name | Dr Ren Masami Kinoshita |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 1301 Punchbowl St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811193816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | DOS-1260 (Hawaii) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Waianae District Comprehensive Health And Hospital Board, Incorporated | 9931008349 | 113 |
News Archive
CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
One only has to be reminded of the BSE crisis and the MMR vaccine scare to recognise the importance of having policy informed by the best available science. Now, a collaboration of over fifty academics and policy makers from around the world have come together to agree a new research agenda on the role of science in public policy.
A new report released today finds that, due to the financial consequences from the Great Recession, many U.S. communities have been unable to make significant progress in preparing to meet the needs of the country's rapidly aging population.
› Verified 9 days ago
| Entity Name | Waianae District Comprehensive Health And Hospital Board, Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275566424 PECOS PAC ID: 9931008349 Enrollment ID: O20040105000833 |
News Archive
CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
One only has to be reminded of the BSE crisis and the MMR vaccine scare to recognise the importance of having policy informed by the best available science. Now, a collaboration of over fifty academics and policy makers from around the world have come together to agree a new research agenda on the role of science in public policy.
A new report released today finds that, due to the financial consequences from the Great Recession, many U.S. communities have been unable to make significant progress in preparing to meet the needs of the country's rapidly aging population.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ren Masami Kinoshita, DO 91-1132 Kaileolea Dr, Ewa Beach, HI 96706-6043 Ph: (808) 779-0780 | Dr Ren Masami Kinoshita, DO 1301 Punchbowl St, Queen's Medical Center, Honolulu, HI 96813-2402 Ph: (808) 779-0780 |
News Archive
CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
One only has to be reminded of the BSE crisis and the MMR vaccine scare to recognise the importance of having policy informed by the best available science. Now, a collaboration of over fifty academics and policy makers from around the world have come together to agree a new research agenda on the role of science in public policy.
A new report released today finds that, due to the financial consequences from the Great Recession, many U.S. communities have been unable to make significant progress in preparing to meet the needs of the country's rapidly aging population.
› Verified 9 days ago
Dr. Heidi M. Solberg-shankle, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Timothy Christopher Laeger, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-3714 | |
Dr. Ina M Vanhest, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 347 N Kuakini St, Honolulu, HI 96817 Phone: 808-547-9593 Fax: 808-599-2714 | |
Dr. Douglas Clark Ostman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3196 Diamond Head Rd, Honolulu, HI 96815 Phone: 808-923-9009 | |
Dr. Perri K Quan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Daniel James Hutchens, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St # 1, Honolulu, HI 96813 Phone: 808-538-9011 | |
Kiera Destiny Glodowski, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1337 Lower Campus Rd Ofc 224, Honolulu, HI 96822 Phone: 808-956-7606 |